731 related articles for article (PubMed ID: 19141154)
1. Rare inherited disorders of fibrinogen.
Acharya SS; Dimichele DM
Haemophilia; 2008 Nov; 14(6):1151-8. PubMed ID: 19141154
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment.
Meeks SL; Abshire TC
Haemophilia; 2008 Nov; 14(6):1159-63. PubMed ID: 19141155
[TBL] [Abstract][Full Text] [Related]
3. Congenital fibrinogen disorders.
de Moerloose P; Neerman-Arbez M
Semin Thromb Hemost; 2009 Jun; 35(4):356-66. PubMed ID: 19598064
[TBL] [Abstract][Full Text] [Related]
4. Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group.
Santacroce R; Cappucci F; Pisanelli D; Perricone F; Papa ML; Santoro R; Grandone E; Margaglione M
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):235-40. PubMed ID: 16651864
[TBL] [Abstract][Full Text] [Related]
5. Congenital fibrinogen disorders: an update.
de Moerloose P; Casini A; Neerman-Arbez M
Semin Thromb Hemost; 2013 Sep; 39(6):585-95. PubMed ID: 23852822
[TBL] [Abstract][Full Text] [Related]
6. Mutational screening of six afibrinogenemic patients: identification and characterization of four novel molecular defects.
Monaldini L; Asselta R; Duga S; Peyvandi F; Karimi M; Malcovati M; Tenchini ML
Thromb Haemost; 2007 Apr; 97(4):546-51. PubMed ID: 17393016
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.
Asselta R; Robusto M; Platé M; Santoro C; Peyvandi F; Duga S
Thromb Res; 2015 Jul; 136(1):168-74. PubMed ID: 26006300
[TBL] [Abstract][Full Text] [Related]
8. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.
Platè M; Asselta R; Spena S; Spreafico M; Fagoonee S; Peyvandi F; Tenchini ML; Duga S
Blood Cells Mol Dis; 2008; 41(3):292-7. PubMed ID: 18676163
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics of quantitative fibrinogen disorders.
Asselta R; Spena S; Duga S; Tenchini ML
Cardiovasc Hematol Agents Med Chem; 2007 Apr; 5(2):163-73. PubMed ID: 17430139
[TBL] [Abstract][Full Text] [Related]
10. Molecular and clinical profile of congenital fibrinogen disorders in Iran, identification of two novel mutations.
Tavasoli B; Safa M; Dorgalaleh A; Ghasemi JB; Rezaei Makhouri F; Rezvani MR; Ahmadi A; Tabibian S; Jazebi M; Baghaipour MR; Zaker F
Int J Lab Hematol; 2020 Oct; 42(5):619-627. PubMed ID: 32639687
[TBL] [Abstract][Full Text] [Related]
11. Treatment of congenital fibrinogen deficiency: overview and recent findings.
Tziomalos K; Vakalopoulou S; Perifanis V; Garipidou V
Vasc Health Risk Manag; 2009; 5():843-8. PubMed ID: 19851522
[TBL] [Abstract][Full Text] [Related]
12. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.
Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P
Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.
Asselta R; Platè M; Robusto M; Borhany M; Guella I; Soldà G; Afrasiabi A; Menegatti M; Shamsi T; Peyvandi F; Duga S
Thromb Haemost; 2015 Mar; 113(3):567-76. PubMed ID: 25427968
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biological features of 3 cases of hypofibrinogenemia associated with three different mutations (gamma Ala341Thr, Bbeta Tyr326Cys and Aalpha Asp496Asn).
Hanss M; Chevreaud C; French P; Négrier C; de Mazancourt P
Thromb Haemost; 2007 Sep; 98(3):689-91. PubMed ID: 17849064
[No Abstract] [Full Text] [Related]
15. Diagnosis of congenital fibrinogen disorders.
Lebreton A; Casini A
Ann Biol Clin (Paris); 2016 Aug; 74(4):405-12. PubMed ID: 27492693
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of fibrinogen deficiency.
Neerman-Arbez M
Pathophysiol Haemost Thromb; 2006; 35(1-2):187-98. PubMed ID: 16855369
[TBL] [Abstract][Full Text] [Related]
17. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.
Casini A; Neerman-Arbez M; Ariëns RA; de Moerloose P
J Thromb Haemost; 2015 Jun; 13(6):909-19. PubMed ID: 25816717
[TBL] [Abstract][Full Text] [Related]
18. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.
Haverkate F; Samama M
Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487
[TBL] [Abstract][Full Text] [Related]
19. Genetic Variants in the
Simurda T; Brunclikova M; Asselta R; Caccia S; Zolkova J; Kolkova Z; Loderer D; Skornova I; Hudecek J; Lasabova Z; Stasko J; Kubisz P
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610551
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations.
Neerman-Arbez M; de Moerloose P
Hum Mutat; 2007 Jun; 28(6):540-53. PubMed ID: 17295221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
